Improvement of glycaemia and endothelial function by a new low-dose curcuminoid in an animal model of type 2 diabetes

Curcumin has been suggested as a promising treatment for metabolic diseases, but the high doses required limit its therapeutic use. In this study, a new curcuminoid is synthesised to increase curcumin anti-inflammatory and antioxidant potential and to achieve hypoglycaemic and protective vascular ef...

ver descrição completa

Detalhes bibliográficos
Autor principal: Oliveira, Sara (author)
Outros Autores: Alfredo, Tamaeh Monteiro-Alfredo; Tamaeh Monteiro (author), Henriques, Rita (author), Ribeiro (author), Seica, Raquel (author), Cruz, Maria Teresa (author), Cabral, C (author), Fernandes, Rosa (author), Piedade, Maria (author), Robalo, Maria Paula (author), Matafome, Paulo (author), Silva, Sónia (author)
Formato: article
Idioma:eng
Publicado em: 2022
Assuntos:
Curcuminoid
Endothelial dysfunction
Glycaemia
Oxidative stress
Type 2 diabetes mellitus
Texto completo:http://hdl.handle.net/10400.21/14719
País:Portugal
Oai:oai:repositorio.ipl.pt:10400.21/14719

Texto Completo

http://hdl.handle.net/10400.21/14719

Registros relacionados